Role of training dose in drug discrimination: A review

Ian P. Stolerman, Emma Childs, Matthew Ford, Kathleen (Kathy) Grant

    Research output: Contribution to journalArticle

    34 Citations (Scopus)

    Abstract

    Drug discrimination has been an important technique in behavioural pharmacology for at least 40 years. The characteristics of drug-produced discriminative stimuli are influenced by behavioural and pharmacological variables, including the doses used to establish discriminations. This review covers studies on the effects of varying the training dose of a drug in a search for general principles that are applicable across different drug classes and methodological approaches. With respect to quantitative changes, relationships between training dose and the rate of acquisition or magnitude of stimulus control were found for most drug classes. Acquisition accelerated with dose up to a point beyond which drug-induced impairments of performance had a deleterious impact. Sensitivity to the training drug as measured by ED50 values typically increased when the training dose was reduced. Qualitative changes were more complex and appeared to fall into three categories: (a) changes in profiles of generalization between partial and full agonists; (b) reduced specificity of some discriminations at small training doses; and (c) changes in the relative salience of actions mediated through different neurotransmitter systems or from central and peripheral sites. Three-lever discrimination procedures incorporating 'drug versus drug' or 'dose versus dose' contingencies enabled detection of more subtle differences than the simple 'drug versus no drug' approach when applied to the opioid, hallucinogen and barbiturate classes of drugs. These conclusions have implications for the interpretation of data from studies that use either within-subject or between-subject designs for studying the discriminative stimulus effects of drugs.

    Original languageEnglish (US)
    Pages (from-to)415-429
    Number of pages15
    JournalBehavioural Pharmacology
    Volume22
    Issue number5-6
    DOIs
    StatePublished - Sep 2011

    Fingerprint

    Pharmaceutical Preparations
    Pharmacology
    Hallucinogens
    Opioid Analgesics
    Neurotransmitter Agents

    Keywords

    • c-aminobutyric acid mimetics
    • cannabinoids
    • drug discrimination
    • ethanol
    • hallucinogens
    • nicotine
    • opioids
    • psychomotor stimulants
    • review

    ASJC Scopus subject areas

    • Pharmacology
    • Psychiatry and Mental health

    Cite this

    Role of training dose in drug discrimination : A review. / Stolerman, Ian P.; Childs, Emma; Ford, Matthew; Grant, Kathleen (Kathy).

    In: Behavioural Pharmacology, Vol. 22, No. 5-6, 09.2011, p. 415-429.

    Research output: Contribution to journalArticle

    Stolerman, Ian P. ; Childs, Emma ; Ford, Matthew ; Grant, Kathleen (Kathy). / Role of training dose in drug discrimination : A review. In: Behavioural Pharmacology. 2011 ; Vol. 22, No. 5-6. pp. 415-429.
    @article{4b952ef1b07f4fb888e4fc5368d55f1d,
    title = "Role of training dose in drug discrimination: A review",
    abstract = "Drug discrimination has been an important technique in behavioural pharmacology for at least 40 years. The characteristics of drug-produced discriminative stimuli are influenced by behavioural and pharmacological variables, including the doses used to establish discriminations. This review covers studies on the effects of varying the training dose of a drug in a search for general principles that are applicable across different drug classes and methodological approaches. With respect to quantitative changes, relationships between training dose and the rate of acquisition or magnitude of stimulus control were found for most drug classes. Acquisition accelerated with dose up to a point beyond which drug-induced impairments of performance had a deleterious impact. Sensitivity to the training drug as measured by ED50 values typically increased when the training dose was reduced. Qualitative changes were more complex and appeared to fall into three categories: (a) changes in profiles of generalization between partial and full agonists; (b) reduced specificity of some discriminations at small training doses; and (c) changes in the relative salience of actions mediated through different neurotransmitter systems or from central and peripheral sites. Three-lever discrimination procedures incorporating 'drug versus drug' or 'dose versus dose' contingencies enabled detection of more subtle differences than the simple 'drug versus no drug' approach when applied to the opioid, hallucinogen and barbiturate classes of drugs. These conclusions have implications for the interpretation of data from studies that use either within-subject or between-subject designs for studying the discriminative stimulus effects of drugs.",
    keywords = "c-aminobutyric acid mimetics, cannabinoids, drug discrimination, ethanol, hallucinogens, nicotine, opioids, psychomotor stimulants, review",
    author = "Stolerman, {Ian P.} and Emma Childs and Matthew Ford and Grant, {Kathleen (Kathy)}",
    year = "2011",
    month = "9",
    doi = "10.1097/FBP.0b013e328349ab37",
    language = "English (US)",
    volume = "22",
    pages = "415--429",
    journal = "Behavioural Pharmacology",
    issn = "0955-8810",
    publisher = "Lippincott Williams and Wilkins",
    number = "5-6",

    }

    TY - JOUR

    T1 - Role of training dose in drug discrimination

    T2 - A review

    AU - Stolerman, Ian P.

    AU - Childs, Emma

    AU - Ford, Matthew

    AU - Grant, Kathleen (Kathy)

    PY - 2011/9

    Y1 - 2011/9

    N2 - Drug discrimination has been an important technique in behavioural pharmacology for at least 40 years. The characteristics of drug-produced discriminative stimuli are influenced by behavioural and pharmacological variables, including the doses used to establish discriminations. This review covers studies on the effects of varying the training dose of a drug in a search for general principles that are applicable across different drug classes and methodological approaches. With respect to quantitative changes, relationships between training dose and the rate of acquisition or magnitude of stimulus control were found for most drug classes. Acquisition accelerated with dose up to a point beyond which drug-induced impairments of performance had a deleterious impact. Sensitivity to the training drug as measured by ED50 values typically increased when the training dose was reduced. Qualitative changes were more complex and appeared to fall into three categories: (a) changes in profiles of generalization between partial and full agonists; (b) reduced specificity of some discriminations at small training doses; and (c) changes in the relative salience of actions mediated through different neurotransmitter systems or from central and peripheral sites. Three-lever discrimination procedures incorporating 'drug versus drug' or 'dose versus dose' contingencies enabled detection of more subtle differences than the simple 'drug versus no drug' approach when applied to the opioid, hallucinogen and barbiturate classes of drugs. These conclusions have implications for the interpretation of data from studies that use either within-subject or between-subject designs for studying the discriminative stimulus effects of drugs.

    AB - Drug discrimination has been an important technique in behavioural pharmacology for at least 40 years. The characteristics of drug-produced discriminative stimuli are influenced by behavioural and pharmacological variables, including the doses used to establish discriminations. This review covers studies on the effects of varying the training dose of a drug in a search for general principles that are applicable across different drug classes and methodological approaches. With respect to quantitative changes, relationships between training dose and the rate of acquisition or magnitude of stimulus control were found for most drug classes. Acquisition accelerated with dose up to a point beyond which drug-induced impairments of performance had a deleterious impact. Sensitivity to the training drug as measured by ED50 values typically increased when the training dose was reduced. Qualitative changes were more complex and appeared to fall into three categories: (a) changes in profiles of generalization between partial and full agonists; (b) reduced specificity of some discriminations at small training doses; and (c) changes in the relative salience of actions mediated through different neurotransmitter systems or from central and peripheral sites. Three-lever discrimination procedures incorporating 'drug versus drug' or 'dose versus dose' contingencies enabled detection of more subtle differences than the simple 'drug versus no drug' approach when applied to the opioid, hallucinogen and barbiturate classes of drugs. These conclusions have implications for the interpretation of data from studies that use either within-subject or between-subject designs for studying the discriminative stimulus effects of drugs.

    KW - c-aminobutyric acid mimetics

    KW - cannabinoids

    KW - drug discrimination

    KW - ethanol

    KW - hallucinogens

    KW - nicotine

    KW - opioids

    KW - psychomotor stimulants

    KW - review

    UR - http://www.scopus.com/inward/record.url?scp=80051942961&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=80051942961&partnerID=8YFLogxK

    U2 - 10.1097/FBP.0b013e328349ab37

    DO - 10.1097/FBP.0b013e328349ab37

    M3 - Article

    C2 - 21808191

    AN - SCOPUS:80051942961

    VL - 22

    SP - 415

    EP - 429

    JO - Behavioural Pharmacology

    JF - Behavioural Pharmacology

    SN - 0955-8810

    IS - 5-6

    ER -